Skip to main content
. 2015 Apr 22;194(11):5497–5508. doi: 10.4049/jimmunol.1401218

FIGURE 7.

FIGURE 7.

Binding properties of hIgG1 Fc-engineered variants toward C1q and complement factors. ELISA results showing binding of WT hIgG1 and Fc-engineered variants to (A) pure hC1q, (B) C1q present in human serum, and (C) pure C1q present in C1q-depleted human serum and activation of complement factors (D) C3 and (E) C5. Experiments were performed at pH 7.4 and results are shown as mean ± SEM of one representative experiment out of three.